Lucas T. Jae

Lucas T. Jae

Auto-generated profile, based on publicly available information

Lucas T. Jae

Gene Center and Department of Biochemistry, Ludwig-Maximilians-Universität München, Munich, Germany

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2015 in Science
Verified
Journal Article
Closed access
PDF file
VBVincent A. Blomen
Vincent A. Blomen
PMPeter Májek
Peter Májek
LJLucas T. Jae
Lucas T. Jae
JBJohannes W. Bigenzahn
Johannes W. Bigenzahn
JNJoppe Nieuwenhuis
Joppe Nieuwenhuis
TBThijn R. Brummelkamp
Thijn R. Brummelkamp
Zeroing in on essential human genes: More powerful genetic techniques are helping to define the list of genes required for the life of a human cell. Two papers used the CRISPR genome editing system and a gene trap method in haploid human cells to screen for essential genes (see the Perspective by Boone and Andrews). Wang et al. 's analysis of multiple cell lines indicates that it may be possible to find tumor-specific dependencies on particular genes. Blomen et al. investigate the phenomenon in which nonessential genes are required for fitness in the absence of another gene. Hence, complexity rather than robustness is the human strategy. Science , this issue p. 1096 and p. 1092 ; see also p. 1028

16 August 2017 in Nature
Verified
Journal Article
Closed access
PDF file
RMRiccardo Mezzadra
Riccardo Mezzadra
CSChong Sun
Chong Sun
LJLucas T. Jae
Lucas T. Jae
RGRaquel Gomez-Eerland
Raquel Gomez-Eerland
EVEvert de Vries
Evert de Vries
TSTon N. M. Schumacher
Ton N. M. Schumacher

4 March 2020 in Nature
Verified
Journal Article
Closed access
PDF file
EFEvelyn Fessler
Evelyn Fessler
EEEva-Maria Eckl
Eva-Maria Eckl
SSSabine Schmitt
Sabine Schmitt
IMIgor Alves Mancilla
Igor Alves Mancilla
MMMatthias F. Meyer-Bender
Matthias F. Meyer-Bender
LJLucas T. Jae
Lucas T. Jae

27 January 2016 in Nature
Verified
Journal Article
Open access
PDF file
SPS. Pillay
S. Pillay
NMN. L. Meyer
N. L. Meyer
APA. S. Puschnik
A. S. Puschnik
ODO. Davulcu
O. Davulcu
JDJ. Diep
J. Diep
JCJan E. Carette
Jan E. Carette
An adeno-associated virus (AAV) receptor protein essential for AAV2 entry into cells is identified; AAV receptor binds directly to the virus, and its ablation renders a diverse range of mammalian cell types and mice resistant to infection by AAV of multiple serotypes. The recent revival of interest in gene therapy has been fueled by the availability of safer and more effective viral gene delivery methods, most notably adeno-associated virus (AAV) vectors. Jan Carette and colleagues now identify a protein that is essential for AAV entry into cells, subsequent to cell attachment. This protein, which they call AAVR, rapidly traffics from the plasma membrane to the trans-Golgi network. The authors show that the virus directly binds to AAVR and that genetic ablation of AAVR renders a diverse range of mammalian cell types and mice resistant to AAV infection. Adeno-associated virus (AAV) vectors are currently the leading candidates for virus-based gene therapies because of their broad tissue tropism, non-pathogenic nature and low immunogenicity1. They have been successfully used in clinical trials to treat hereditary diseases such as haemophilia B (ref. 2), and have been approved for treatment of lipoprotein lipase deficiency in Europe3. Considerable efforts have been made to engineer AAV variants with novel and biomedically valuable cell tropisms to allow efficacious systemic administration1,4, yet basic aspects of AAV cellular entry are still poorly understood. In particular, the protein receptor(s) required for AAV entry after cell attachment remains unknown. Here we use an unbiased genetic screen to identify proteins essential for AAV serotype 2 (AAV2) infection in a haploid human cell line. The most significantly enriched gene of the screen encodes a previously uncharacterized type I transmembrane protein, KIAA0319L (denoted hereafter as AAV receptor (AAVR)). We characterize AAVR as a protein capable of rapid endocytosis from the plasma membrane and trafficking to the trans-Golgi network. We show that AAVR directly binds to AAV2 particles, and that anti-AAVR antibodies efficiently block AAV2 infection. Moreover, genetic ablation of AAVR renders a wide range of mammalian cell types highly resistant to AAV2 infection. Notably, AAVR serves as a critical host factor for all tested AAV serotypes. The importance of AAVR for in vivo gene delivery is further highlighted by the robust resistance of Aavr−/− (also known as Au040320−/− and Kiaa0319l−/−) mice to AAV infection. Collectively, our data indicate that AAVR is a universal receptor involved in AAV infection.

26 April 2013 in Science
Verified
Journal Article
Closed access
PDF file
LJLucas T. Jae
Lucas T. Jae
MRMatthijs Raaben
Matthijs Raaben
MRMoniek Riemersma
Moniek Riemersma
EBEllen van Beusekom
Ellen van Beusekom
VBVincent A. Blomen
Vincent A. Blomen
TBThijn R. Brummelkamp
Thijn R. Brummelkamp
Viruses and Congenital Disorders: Mutations in genes involved in α-dystroglycan O-linked glycosylation result in posttranslation modifications associated with the congenital disease Walker-Warburg syndrome (WWS). This cellular modification is also required for efficient Lassa virus infection of cells. Jae et al. (p. 479 , published online 21 March) screened for genes involved in O-glycosylation that affected Lassa virus infection and identified candidates involved in glycosylation. Individuals from different pedigrees exhibiting WWS had unique mutations among genes identified in the genetic screen. Thus, comprehensive forward genetic screens can be used to define the genetic architecture of a complex disease.

27 June 2014 in Science
Verified
Journal Article
Closed access
PDF file
LJLucas T. Jae
Lucas T. Jae
MRMatthijs Raaben
Matthijs Raaben
AHAndrew S. Herbert
Andrew S. Herbert
AKAna I. Kuehne
Ana I. Kuehne
AWAriel S. Wirchnianski
Ariel S. Wirchnianski
TBThijn R. Brummelkamp
Thijn R. Brummelkamp
How Lassa virus breaks and enters: Lassa virus, which spreads from rodents to humans, infecting about half a million people every year, can lead to deadly hemorrhagic fever. Like many viruses, Lassa virus binds to cell surface receptors. Jae et al. now show that to enter a cell, the virus requires a second receptor, this one inside the infected cell. This requirement sheds light on the “enigmatic resistance” of bird cells to Lassa virus observed three decades ago. Although bird cells have the cell surface receptor, the intracellular receptor cannot bind the virus, stopping it in its tracks. Science , this issue p. 1506